Evidence map›Paper›PMID 20960273›Full record

ArticleEndocrine2010

Graves' disease and gene polymorphism of TNF-α, IL-2, IL-6, IL-12, and IFN-γ.

Mehdi Anvari, Omid Khalilzadeh, Alireza Esteghamati, Fatemeh Momen-Heravi, Mahdi Mahmoudi, Shadi Abdar Esfahani, Armin Rashidi, Aliakbar Amirzargar

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Tocilizumab for thyroid eye disease.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Association ofBioscience reports · 2018
    Pooled it
  4. Article
  5. Melatonin, an Antitumor Necrosis Factor Therapy.Journal of pineal research · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mehdi AnvariMolecular Immunology and Immunogenetics Research Center, Tehran University of Medical Sciences, Tehran, Iran. mehdi.anvari1@gmail.com
Omid Khalilzadeh
Alireza Esteghamati
Fatemeh Momen-Heravi
Mahdi Mahmoudi
Shadi Abdar Esfahani
Armin Rashidi
Aliakbar Amirzargar
Tehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of genetic factors in the pathogenesis of Graves' disease (GD) is not clear. The purpose of this study was to investigate the association between single nucleotide polymorphisms in pro-inflammatory cytokine genes and GD in Iranian patients. A case-control hospital-based study was carried out on 107 GD patients and 140 healthy controls. Cytokine typing was performed by polymerase chain reaction with sequence-specific primers (PCR-SSP) assay. The allele and genotype frequencies of the following cytokine genes were determined: TNF-α (-308A/G, -238A/G), IL-2 (-330T/G, +166G/T), IL-6 (-174C/G, A/G nt565), IL-12 (-1188A/C), and IFN-γ (UTR 5644A/T). The following alleles and genotypes were significantly overrepresented in patients: TNF-α -308A allele (P < 0.01) and AA genotype (P < 0.05), IL-2 -330G allele (P < 0.01) and GG genotype (P < 0.01), IL-6 -174C allele (P < 0.01) and CC genotype (P < 0.01), IL-12 -1188C allele (P < 0.01) and CC genotype (P < 0.01), IFN-γ UTR5644T allele (P < 0.01) and TT genotype (P < 0.01). In conclusion, this is the first study to show a significant association between GD and IL-2 -330G, IL-12 -1188C, and IFN-γ UTR 5644T alleles. Our results support the hypothesis that polymorphism in pro-inflammatory cytokines might be involved in predisposition to GD.

Indexed as

Polymorphism, Single NucleotideCase-Control StudiesCytokinesGenetic Predisposition to DiseaseGenotypeGraves DiseaseHumansInterferon-gammaInterleukin-12Interleukin-2Interleukin-6Tumor Necrosis Factor-alphaCytokinesIL6 protein, humanInterferon-gammaInterleukin-12Interleukin-2Interleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID20960273
OpenAlexW2071452259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.